- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04854226
Protein Turnover in Preterm Infants - Feeding of Target Fortified Breast Milk With Different Macronutrient Composition to Improve Growth
February 27, 2023 updated by: Niels Rochow, MD, PhD, Paracelsus Medical University
Protein Turnover in Preterm Infants - Feeding of Target Fortified Breast Milk With Different Carbohydrate and Fat Composition to Improve Growth
The purpose of this study is to measure protein turnover rates in preterm infants.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
After being informed about the study and potential risks, all parents giving written informed consent the principal investigator will determine the eligibility for study entry.
Patients who met the eligibility requirements will be randomized in a double-blind manner in a 1:1 ratio to fortified breast milk with higher fat composition to fortified breast milk with higher carbohydrate composition.
Both groups will receive a stable protein composition.
The participants will receive the intervention for 3 consecutive weeks.
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christoph Fusch, Prof. Dr. med.
- Phone Number: +49911 398-2307
- Email: christoph.fusch@klinikum-nuernberg.de
Study Contact Backup
- Name: Niels Rochow, PD Dr. med.
- Phone Number: +49911-398-118903
- Email: Niels.Rochow@klinikum-nuernberg.de
Study Locations
-
-
-
Nürnberg, Germany, 90471
- Recruiting
- Klinik für Neugeborene, Kinder und Jugendliche Universitätsklinik der Paracelsus Medizinischen Privatuniversität
-
Contact:
- Christoph Fusch, Prof. Dr. med.
- Phone Number: +49911398-2307
- Email: christoph.fusch@klinikum-nuernberg.de
-
Contact:
- Niels Rochow, PD Dr. med.
- Phone Number: +49911398-118903
- Email: Niels.Rochow@klinikum-nuernberg.de
-
Rostock, Germany, 18057
- Not yet recruiting
- Universitätsmedizin Rostock Kinder und Jugendklinik
-
Contact:
- Jan Däbritz, Prof. Dr. med.
- Phone Number: +49381-494 7001
- Email: jan.daebritz@med.uni-rostock.de
-
Contact:
- Klaus Wutzke, Prof.
- Email: klaus-dieter.wutzke@uni-rostock.de
-
Rostock, Germany, 18059
- Not yet recruiting
- Klinikum Südstadt Rostock Abteilung für Neonatologie und Neonatologische Intensivmedizin
-
Contact:
- Dirk Manfred Olbertz, PD Dr . med.
- Phone Number: 5500 +49381 4401
- Email: dirk.olbertz@kliniksued-rostock.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 months to 7 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Gestational age < 32 weeks
- Enteral nutrition >150 mL / kg / d
Exclusion Criteria:
- gastrointestinal malformations
- Enterostoma
- short bowel syndrome
- necrotizing enterocolitis
- kidney disease
- Foreseeable transfer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Macronutrient_CARB
High carbs, low fat composition.
|
Breast milk 150 to 170 mL/d; Target fortification: 9.0 g/100mL COH, 3.0 g/100mL protein, 4.0 g/100mL fat, 86.4 kcal/100mL
|
|
Active Comparator: Macronutrient_FAT
Low carbs, high fat composition.
|
Breast milk 150 to 170 mL/d; Target fortification: 5.5 g/100mL COH, 3.0 g/100mL protein, 5.5 g/100mL fat, 86 kcal/100mL
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
weight gain
Time Frame: daily for 3 weeks
|
weight gain in gram
|
daily for 3 weeks
|
|
Protein turnover and net protein gain
Time Frame: weekly for 3 weeks
|
Tracer N15 labelled amino acids
|
weekly for 3 weeks
|
|
Protein excretion
Time Frame: weekly for 3 weeks
|
Urinary urea in mg/dL and urine volume in mL will be combined to report protein excretion per urine sample (g/kg/d).
|
weekly for 3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nutritional intake
Time Frame: daily for 3 weeks
|
Volume of Breast Milk in mL/kg/d, Lactose in g/100mL, protein g/100mL, fat g/100mL will be combinded to report energy in kcal/kg/d
|
daily for 3 weeks
|
|
head circumference
Time Frame: daily for 3 weeks
|
in cm
|
daily for 3 weeks
|
|
body length
Time Frame: daily for 3 weeks
|
in cm
|
daily for 3 weeks
|
|
body composition
Time Frame: weekly for 3 weeks
|
Fat mass in g, fat-free mass g, volume in L will be combined to report body density in kg/L
|
weekly for 3 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 21, 2021
Primary Completion (Anticipated)
August 31, 2024
Study Completion (Anticipated)
August 31, 2024
Study Registration Dates
First Submitted
April 12, 2021
First Submitted That Met QC Criteria
April 16, 2021
First Posted (Actual)
April 22, 2021
Study Record Updates
Last Update Posted (Estimate)
February 28, 2023
Last Update Submitted That Met QC Criteria
February 27, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SZ_D_069_20-IX-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant Development
-
Société des Produits Nestlé (SPN)RecruitingInfant Development | Growth and Development | Infant Health | Infant Formula | Infant Nutritional Physiological PhenomenaSaudi Arabia
-
University of ArizonaMead Johnson NutritionActive, not recruiting
-
Bartosz M. RadtkeRecruitingChild Development | Infant Development | Early Childhood DevelopmentPoland
-
Children's Hospital Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingInfant DevelopmentGuatemala
-
Northwestern UniversityStanford UniversityCompleted
-
University Hospital, MontpellierCompletedInfant DevelopmentFrance
-
Bellamy's Organic Pty LtdActive, not recruitingInfant DevelopmentChina
-
Columbia UniversityCompleted
-
Centre Hospitalier Intercommunal CreteilCompleted
-
University of WashingtonNational Institute of Neurological Disorders and Stroke (NINDS)TerminatedInfant DevelopmentUnited States